Showing results (1061-1070 of 3,636) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|February 2, 2013
Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han womenHui Xie, Kai Xia, Hui Rong, et al.Breast (Edinburgh, Scotland)|February 5, 2013
The use of one step nucleic-acid amplification (OSNA) in clinical practice: a single-centre studyDionysios D Remoundos, Vivien V Ng, Hannah A Wilson, et al.Breast (Edinburgh, Scotland)|March 12, 2013
Waiting time disparities in breast cancer diagnosis and treatment: a population-based study in FranceF Molinié, C Leux, P Delafosse, et al.Breast (Edinburgh, Scotland)|March 13, 2013
Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyondWolfgang Gatzemeier, G Bruce MannBreast (Edinburgh, Scotland)|May 8, 2012
Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer developmentGeorge E Theodoropoulos, Vasilios Saridakis, Theodoros Karantanos, et al.Breast (Edinburgh, Scotland)|May 19, 2012
Breast reconstruction following mastectomy for invasive breast cancer is strongly influenced by demographic factors in women in Victoria, AustraliaR J Bell, P J Robinson, P Fradkin, et al.Breast (Edinburgh, Scotland)|May 1, 2012
Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trialsNan Shao, Shenming Wang, Chen Yao, et al.Breast (Edinburgh, Scotland)|March 5, 2013
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trialDiana Crivellari, Kathryn P Gray, Silvia Dellapasqua, et al.Breast (Edinburgh, Scotland)|March 5, 2013
Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?M Aapro, C J H van de Velde, C Markopoulos, et al.Breast (Edinburgh, Scotland)|March 7, 2013
Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal womenAdnan AydinerPageof 364